CLRB vs RVTY · $20.8M cap vs P/E 42, rev $1.44B
Cellectar Biosciences Inc (CLRB) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
Cellectar Biosciences Inc (CLRB) is a biotechnology company listed on US.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
CLRB does not have a complete income-statement cache yet.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
CLRB currently screens at market cap $20.8M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the CLRB and RVTY stock pages for the full models.
Not investment advice.